Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01818414 · ClinicalTrials.gov registry record · NA
Same-day Dilapan-S With Adjunctive Misoprostol
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT01818414 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 29 participants.
The verdict
NCT01818414, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Cervical preparation before second trimester dilation and evacuation (D\&E) reduces risks and complications. Osmotic cervical dilators as well as prostaglandin analogues have been studied for cervical preparation. However, the optimal method for cervical preparation, especially for D\&E procedures that occur on the same day as cervical preparation, is not known. This study will investigate misoprostol versus placebo as an adjunct to Dilapan-S for cervical preparation for same-day D\&E between 16+0 and 20+6 weeks gestation. HYPOTHESIS: Administration of 400 µg buccal misoprostol compared to placebo at least 3 hours prior to D\&E as an adjunct to cervical preparation with Dilapan-S will decrease operative time for same-day D\&E performed between 16+0 and 20+6 weeks.
Interventions
- DRUG Misoprostol
- DRUG Folic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01818414
The ClinicalTrials.gov registry entry for NCT01818414 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Misoprostol is the first listed.
NCT01818414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01818414 about?
NCT01818414 is a clinical study titled "Same-day Dilapan-S With Adjunctive Misoprostol". Cervical preparation before second trimester dilation and evacuation (D\&E) reduces risks and complications. Osmotic cervical dilators as well as prostaglandin analogues have been studied for cervical preparation. However, the optimal method for cervical preparation, especially for D\&E procedures t...
What is the current status of trial NCT01818414?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2013-10. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01818414?
The interventions under investigation include: Misoprostol (DRUG), Folic Acid (DRUG).
Who is sponsoring clinical trial NCT01818414?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.